Amendment history : Erratum ( May 2016 ) Matricellular protein CCN 3 mitigates abdominal aortic aneurysm
暂无分享,去创建一个
J. Golledge | J. Moxon | P. Norman | H. Kuivaniemi | K. Yokote | S. Gerson | M. Takemoto | Rongli Zhang | B. Perbal | G. Shi | N. Dong | L. Rittié | S. Hiraoka | Domenick A. Prosdocimo | Chao Zhang | Zhiyong Lin | Hong Shi | G. Atkins | Yulan Qing | D. V. D. Voort | Stanton L. Gerson | Bernard Perbal | Nianguo Dong | Zhiyong Lin | Koutaro Yokote | Helena Kuivaniemi | Paul E. Norman | Hong Shi | Rongli Zhang | Shuichi Hiraoka | Guo-Ping Shi | J. Golledge
[1] Jay D. Humphrey,et al. Mechanotransduction and extracellular matrix homeostasis , 2014, Nature Reviews Molecular Cell Biology.
[2] V. Weaver,et al. Extracellular matrix assembly: a multiscale deconstruction , 2014, Nature Reviews Molecular Cell Biology.
[3] G. Shi,et al. Vascular wall extracellular matrix proteins and vascular diseases. , 2014, Biochimica et biophysica acta.
[4] Proteomic and genomic analyses suggest the association of apolipoprotein C1 with abdominal aortic aneurysm , 2014, Proteomics. Clinical applications.
[5] A. Daugherty,et al. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies , 2014, Heart.
[6] P. Libby,et al. IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms , 2014, EMBO molecular medicine.
[7] G. Upchurch,et al. CARDIOVASCULAR , PULMONARY , AND RENAL PATHOLOGY Phosphorylation of AKT and Abdominal Aortic Aneurysm Formation , 2013 .
[8] Shing‐Jong Lin,et al. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway. , 2013, Cardiovascular research.
[9] J. Bavaria,et al. Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. , 2013, Cardiovascular research.
[10] Heng Wan,et al. CCN4 regulates vascular smooth muscle cell migration and proliferation , 2013, Molecules and cells.
[11] A. Daugherty,et al. Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms. , 2013, Current opinion in pharmacology.
[12] J. Golledge,et al. Everolimus Limits Aortic Aneurysm in the Apolipoprotein E–Deficient Mouse by Downregulating C-C Chemokine Receptor 2 Positive Monocytes , 2013, Arteriosclerosis, Thrombosis and Vascular Biology.
[13] J. Golledge,et al. Transforming growth factor-β and abdominal aortic aneurysms. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[14] B. Perbal. CCN proteins: A centralized communication network , 2013, Journal of Cell Communication and Signaling.
[15] J. Coselli,et al. AKT2 Confers Protection Against Aortic Aneurysms and Dissections , 2013, Circulation research.
[16] Karen Cheng,et al. Loss of CDKN2B Promotes p53-Dependent Smooth Muscle Cell Apoptosis and Aneurysm Formation , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[17] J. Coselli,et al. Notch Signaling in Descending Thoracic Aortic Aneurysm and Dissection , 2012, PloS one.
[18] R. Schwartz,et al. Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function , 2012, Nature Medicine.
[19] M. Eagleton,et al. Local and systemic alterations in signal transducers and activators of transcription (STAT) associated with human abdominal aortic aneurysms. , 2012, The Journal of surgical research.
[20] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[21] Cheng Zhang,et al. Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo , 2012, Nature Medicine.
[22] P. Tsao,et al. MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion , 2012, Science Translational Medicine.
[23] Alicia Deng,et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. , 2012, The Journal of clinical investigation.
[24] Lester F. Lau,et al. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets , 2011, Nature Reviews Drug Discovery.
[25] J. Redondo,et al. Regulator of calcineurin 1 mediates pathological vascular wall remodeling , 2011, The Journal of experimental medicine.
[26] R. Charnigo,et al. Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. , 2011, The American journal of pathology.
[27] J. Golledge,et al. Current status of medical management for abdominal aortic aneurysm. , 2011, Atherosclerosis.
[28] S. Lemaire,et al. Epidemiology of thoracic aortic dissection , 2011, Nature Reviews Cardiology.
[29] L. Rodella,et al. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. , 2011, Human gene therapy.
[30] J. Golledge,et al. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. , 2010, Atherosclerosis.
[31] Saptarsi M. Haldar,et al. Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation , 2010, Science Translational Medicine.
[32] Caili Hao,et al. A novel role of CCN3 in regulating endothelial inflammation , 2010, Journal of Cell Communication and Signaling.
[33] Magdi H. Yacoub,et al. Cellular and molecular mechanisms of thoracic aortic aneurysms , 2009, Nature Reviews Cardiology.
[34] P. Holt,et al. Review of Current Theories for Abdominal Aortic Aneurysm Pathogenesis , 2009, Vascular.
[35] N. Weintraub,et al. Understanding abdominal aortic aneurysm. , 2009, The New England journal of medicine.
[36] L. Lau,et al. Functions and mechanisms of action of CCN matricellular proteins. , 2009, The international journal of biochemistry & cell biology.
[37] A. Irvine,et al. CCN3--a key regulator of the hematopoietic compartment. , 2009, Blood reviews.
[38] 下山 立志. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration , 2009 .
[39] W. Buurman,et al. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration , 2009, Nature Reviews Cardiology.
[40] J. Golledge,et al. Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm , 2009, BMC Genomics.
[41] A. Boddy,et al. Basic research studies to understand aneurysm disease. , 2008, Drug news & perspectives.
[42] M. Halks-Miller,et al. Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice , 2008, Gene Therapy.
[43] H. Yeger,et al. The CCN family of genes: a perspective on CCN biology and therapeutic potential , 2007, Journal of Cell Communication and Signaling.
[44] 松前 宏信. CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model , 2008 .
[45] M. Aoki,et al. Regression of Abdominal Aortic Aneurysms by Simultaneous Inhibition of Nuclear Factor &kgr;B and Ets in a Rabbit Model , 2007, Circulation research.
[46] Gerard Tromp,et al. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms , 2007, BMC Genomics.
[47] T. Enver,et al. NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells , 2007, Science.
[48] N. Weintraub,et al. Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[49] Peter Libby,et al. Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[50] R. Ricci,et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.
[51] M M Thompson,et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[52] M. Halks-Miller,et al. Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis , 2005, Circulation.
[53] Naoya Nakai,et al. Essential role for ERK2 mitogen‐activated protein kinase in placental development , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[54] L. Lau,et al. CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family* , 2003, Journal of Biological Chemistry.
[55] L. Lau,et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. , 2002, Blood.
[56] L. Lau,et al. The Angiogenic Factor Cysteine-Rich 61 (CYR61, CCN1) Supports Vascular Smooth Muscle Cell Adhesion and Stimulates Chemotaxis through Integrin α6β1 and Cell Surface Heparan Sulfate Proteoglycans. , 2002, Endocrinology.
[57] A. Daugherty,et al. Antagonism of AT2 receptors augments Angiotensin II‐induced abdominal aortic aneurysms and atherosclerosis , 2001, British journal of pharmacology.
[58] J. Sweatt,et al. Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. , 2001, Learning & memory.
[59] W. Fan,et al. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. , 2000, European journal of cell biology.
[60] Qin Chen,et al. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[61] S. Shapiro,et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.
[62] A Daugherty,et al. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.
[63] L. Lau,et al. Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.
[64] P. Schofield,et al. novH: differential expression in developing kidney and Wilm's tumors. , 1998, The American journal of pathology.
[65] T. V. Kolesnikova,et al. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] W. März,et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. , 1997, Circulation.
[67] V. Joliot,et al. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.